Micro-engineered poly(HEMA) hydrogel for wearable contact lens biosensing and other applications
Microchannels in hydrogels play an essential role in enabling a smart contact lens. A wearable contact lens is disclosed herein that uses microchannels and connected chambers located in poly-2-hydroxyethyl methacrylate (poly(HEMA)) hydrogel that is used in a commercial contact lens with three-dimensional (3D) printed mold. The corresponding capillary flow behaviors in these microchannels were investigated. Different capillary flow regimes were observed in these microchannels, depending on the hydration level of the hydrogel material. In particular, it was found that a peristaltic pressure could reinstate flow in a dehydrated microchannel, indicating the motion of eye-blinking may help tear flow in a microchannel-containing contact lens. Colorimetric pH and electrochemical Na + sensing capabilities were demonstrated in these microchannels. Micro-engineered contact lenses formed using poly(HEMA) hydrogel can be used for various biomedical applications such as eye-care and wearable biosensing.
1 . A contact lens comprising:
a lens body comprising a base layer and a capping layer, both the base layer and the capping layer comprising poly-2-hydroxyethyl methacrylate (poly (HEMA)) hydrogel, the base layer having formed therein one or more microchannels and a plurality of chambers, the one or more microchannels connected to the plurality of chambers, the capping layer bonded to the base layer and overlying the one or more microchannels and the plurality of chambers;
an inlet fluidically coupled to one of the plurality of chambers and an outlet fluidically coupled to one of the plurality of chambers; and
an electrochemical sensing electrode disposed in one or more of the plurality of chambers or the one or more microchannels, wherein the electrochemical sensing electrode comprises poly (3,4-ethylenedioxythiophene) polystyrene sulfonate PEDOT:PSS) having a sodium ionophore disposed thereon.
2 . The contact lens of claim 1 , wherein one or more of the plurality of chambers are connected at least two microchannels.
3 . The contact lens of claim 1 , further comprising a therapeutic agent disposed in one or more of the plurality of chambers or the one or more microchannels.
4 . The contact lens of claim 1 , wherein the one or more microchannels have a width between about 10 μm and 800 μm.
5 . The contact lens of claim 1 , wherein the one or more microchannels have a height between about 10 μm and 800 μm.
6 . The contact lens of claim 2 , wherein one or more of the plurality of chambers comprises a reagent contained therein.
7 . A method of forming a contact lens with one or more microchannels formed therein comprising:
(a) providing a mold having reverse features of the one or more microchannels and the plurality of chambers;
(b) casting poly-2-hydroxyethyl methacrylate (poly (HEMA)) precursor mixture on the mold, the precursor mixture comprising HEMA, a free-radical initiator, and a crosslinking agent to form a poly (HEMA) base layer;
(c) removing the poly (HEMA) base layer from the mold;
(d) subjecting the poly (HEMA) base layer to plasma treatment or applying the poly (HEMA) precursor mixture to the poly (HEMA) base layer after removing the poly (HEMA) base layer from the mold; and
(e) securing a poly (HEMA) capping layer to the poly (HEMA) layer after operation (d).
8 . The method of claim 7 , wherein the mold having the reverse features has a polymer anti-adhesion layer formed thereon.
9 . The method of claim 7 , further comprising flattening the poly (HEMA) base layer removed from the mold prior to securing the poly (HEMA) capping layer.
10 . A method of using the contact lens of claim 1 , comprising:
inserting the contact lens onto the eye of a mammalian subject.
11 . The method of claim 10 , wherein blinking of the eye causes fluid flow through the one or more microchannels.
12 . The method of claim 11 , wherein the flow comprises peristaltic pressure-induced flow.
13 . The method of claim 11 , wherein the flow comprises spontaneous capillary flow.
14 . The method of claim 10 , further comprising sensing the osmolarity of tear passing along one or more microchannels or one of the plurality of chambers with the electrochemical sensing electrode.
15 . The method of claim 10 , further comprising delivering a therapeutic agent contained in the contact lens to the eye of the mammalian subject.
16 . The method of claim 15 , wherein the therapeutic agent is disposed in the one or more microchannels or at least one of the plurality of chambers in dry form and solubilized by tear.